To develop and maintain relationships with industry members and with world regulatory agencies to address issues related to cartilage repair
Devise and disseminate an ICRS consensus opinion on regulatory matters confronting World Regulatory agencies regarding Cell therapies and scaffold Technology. Develop and maintain relationships with Regulatory bodies such as the FDA , EMEA, AMA and other world regulatory bodies. Host and develop joint meetings including regulators, industry representatives, scientists and physicians for the purpose of maintaining lines of communication and fostering better understanding between the various stakeholders. Develop and maintain relationships with Industry members and aide Scientific Program Committee and Executive Director in fostering sponsorship opportunities for the Society and its Scientific Program meeting
The committee members and Chair will be elected and serve as delineated in the Election Procedures.
The committee shall consist of at least 6 members and not more than 8. At least one member will be an Industry representative ad at least one other member should be a Non-physician, Scientist member.
Phoenix, United States of America
University Hospital Regensburg Klinik für Unfallchirurgie, Traumatologie Regensburg, Germany
University of Pennsylvania Department of Orthopaedic Surgery Philadelphia, United States of America
CartiHeal Kfar Saba, Israel
University of Colorado School of Medicine Department of Orthopaedic Surgery Aurora, United States of America
Geistlich Pharma AG Business Unit Surgery Wolhusen, Switzerland
Center for Advanced Sports Medicine Knee & Shoulder Millburn, United States of America